Mahmood S, Islam M M, Siddiqui N I, Hossain G A, Chakraborty R K, Akhter N, Meah I
Centre for Nucler Medicine and Ultrasound (CNMU), Mymensingh, PO Box No 47, Mymensingh-2200, Bangladesh.
Mymensingh Med J. 2004 Jan;13(1):4-10.
The region of greater Mymensingh known for iodine endemicity, recently came under iodine supplementation as a result of mandatory universal iodination of salt program. Autoimmune thyroid diseases (AITD) are among the most common human autoimmune disorders & presence of autoantibodies to the microsomal antigen (AntiMCAb) is a hallmark of disease activity. Both iodine deficiency & iodine supplementation precipitate increase rate of autoimmunity to the thyroid gland. Study was undertaken to determine prevalence of AntiMCAb positive cases among patients with various thyroid diseases. High resolution ultrasound (HRUS), serum thyroid hormone assays & scintiscan were used to classify the thyroid patients into 8 categories. 221 patients were studied during the stipulated period of 3 months. Male patients were 60 & female patients were 161. Age ranged from 11 to 65 years with median age 29.4 years. AntiMCAb test were done with radioimmunoassay (RIA). 126 patients had antimicrosomal antibody (57.01%). All form of hypothyroid (atrophic, goitrous, Hashimoto's) have very high rate of AntiMCAb positive cases. Highest 89.28% were seen in patients showing feature of Hashimoto's thyroiditis or generalized feature of AITD in HRUS with hypothyroidism, followed had 61.29% positive cases, However, antithyroid antibody was found in all form of thyroid disorders. Nodular goiter had 21.73% antiMCAb positive cases. AntiMCAb found positive at the rate of 33.33% in euthyroid patients with HRUS feature of AITD & diffuse euthyroid goiter, 40% in subclinical hypothyroid, 40% in subclinical hyperthyroid. Female rated higher in range of antimicrosomal antibody positivism. 59% of all thyroid patients among female subjects were AntMCAb positive, where as 51.67% male thyroid patients were positive. Highest number of positive cases found in the 30-35 age group. No definite pattern, however, was observed among age distribution. 20 age matched sample from patients unsuspected of thyroid disease shows 10% AntiMCAb positive compared to 73.33% of the same among same age group of thyroid patients. Frank Hashimoto's thyroiditis with positive antiMCAb and hypothyroidism were all detected by HRUS.
迈门辛希较大地区以碘缺乏病流行而闻名,最近由于食盐强制普遍碘化计划而开始进行碘补充。自身免疫性甲状腺疾病(AITD)是最常见的人类自身免疫性疾病之一,针对微粒体抗原的自身抗体(抗微粒体抗体,AntiMCAb)的存在是疾病活动的标志。碘缺乏和碘补充都会促使甲状腺自身免疫发生率增加。本研究旨在确定各类甲状腺疾病患者中抗微粒体抗体阳性病例的患病率。使用高分辨率超声(HRUS)、血清甲状腺激素检测和闪烁扫描将甲状腺疾病患者分为8类。在规定的3个月期间对221名患者进行了研究。男性患者60例,女性患者161例。年龄范围为11至65岁,中位年龄为29.4岁。抗微粒体抗体检测采用放射免疫分析法(RIA)。126例患者抗微粒体抗体呈阳性(57.01%)。所有类型的甲状腺功能减退症(萎缩性、甲状腺肿性、桥本氏病)抗微粒体抗体阳性病例的发生率都非常高。在高分辨率超声检查显示甲状腺功能减退且具有桥本甲状腺炎特征或AITD全身特征的患者中,抗微粒体抗体阳性率最高,为89.28%,其次为61.29%的阳性病例。然而,在所有类型的甲状腺疾病中均发现了抗甲状腺抗体。结节性甲状腺肿抗微粒体抗体阳性病例占21.73%。在具有AITD高分辨率超声特征的甲状腺功能正常患者和弥漫性甲状腺肿性甲状腺功能正常患者中,抗微粒体抗体阳性率为33.33%,亚临床甲状腺功能减退症中为40%,亚临床甲状腺功能亢进症中为40%。女性抗微粒体抗体阳性率更高。女性甲状腺患者中59%抗微粒体抗体呈阳性,而男性甲状腺患者中这一比例为51.67%。抗微粒体抗体阳性病例数在30 - 35岁年龄组中最多。然而,在年龄分布中未观察到明确的模式。20例未怀疑患有甲状腺疾病的年龄匹配患者样本中,抗微粒体抗体阳性率为10%,而在同一年龄组的甲状腺疾病患者中这一比例为73.33%。抗微粒体抗体阳性且甲状腺功能减退的典型桥本甲状腺炎均通过高分辨率超声检查检测到。